Captain T Cell secures seed financing round

Captain T Cell, a spin-off from the Max Delbrück Center, raised €8.5 million in startup funding. The startup focuses on developing T cells to target solid tumors. The funds are intended to move a new generation of T cell therapies towards the clinic.

3 Min
More

€700,000 boost for preeclampsia research

Preeclampsia is one of the most common pregnancy-related complications. Florian Herse of the Max Delbrück Center and Martin Gauster of the Medical University of Graz are studying the role that Hofbauer cells play in the disorder. They have been…

3 Min
More

Current Topics in Bioinformatics 2024: „Advances in single cell- and spatially resolved technologies“

Join us at this year's "Current Topics in Bioinformatics" symposium, where we'll explore single cell- and spatially resolved technologies.

1 Min
More

A Sugar-Code Tweaked with Fluorine Against Meningitis

The innovative combination of complex sugars and fluorine is a promising initial step towards developing more effective vaccines against some bacteria that cause meningitis. The compound designed by Peter Seeberger and Ryan Gilmour (University of…

2 Min
More

Researchers of the BIH decipher mechanisms of liver regeneration

Scientists from the Berlin Institute of Health at Charité (BIH) and Open Targets together with colleagues from the University of Cambridge, and Addenbrooke’s Hospital in Cambridge, UK, uncovered mechanisms driving regeneration of the liver during…

6 Min
More

Charité study in Nature: How cells deal with extra chromosomes

Having extra chromosomes is typically an issue for an organism and can disrupt development or cause disease. But some cells benefit instead: For example, cancer cells or pathogenic yeasts can use extra chromosomes to escape treatment and become…

4 Min
More

Pathoblockers, a Future Alternative to Antibiotics? - Researchers at Freie Universität Berlin and Charité – Universitätsmedizin Berlin “defanging” bacteria, rendering them harmless

In most cases, antibiotics are a reliable form of protection against bacterial infections. They have saved billions of human lives since their introduction. This protection, however, is threatened by bacteria’s resistance to classical antibiotics and…

2 Min
More

BIH Researchers develop theory on traveling waves of activity in the human brain

Researchers at the Berlin Institute of Health at Charité (BIH) have used brain simulations to develop a theory on the formation of traveling waves of activity. These waves influence cognitive processes in the human brain such as learning or…

3 Min
More

Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.

Berlin, 14 May 2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased sales by 17% to € 67.6 million in the first quarter of 2024 compared to the same period of the previous year. EBIT before special items from continuing operations…

2 Min
More

Aignostics recognized among Newsweek’s “World’s Best Digital Health Companies 2024"

Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”

1 Min
More
Show more items